HANGZHOU, China, Nov. 23, 2023 /PRNewswire/ -- Broncus(2216.HK) is pleased to announce that, on November 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it..

中国杭州，2023年11月23日/PRNewswire/-Broncus（2216.HK）很高兴地宣布，2023年11月23日，Broncus杭州（Broncus的整体子公司，作为受让人）已签订股权转让协议与杭州景亮股东达成协议，收购其100%股权。。

Broncus is a pioneering medical device company in the field of interventional pulmonology which provides precise interventional diagnosis and treatment solutions for lung diseases for doctors and patients worldwide, and develops a full set of integrated interventional pulmonology platforms for navigation, diagnosis and treatment.

Broncus是介入肺病学领域的开拓性医疗器械公司，为全球医生和患者提供精确的肺部疾病介入诊断和治疗解决方案，并开发全套导航，诊断和治疗介入肺病综合平台。

It has addressed unmet clinical needs to a certain extent..

它在一定程度上解决了未满足的临床需求。。

Surgical robots, given their ability to complete precise surgical operations in the narrow space within the human body cavity, have been an important innovative intelligent medical device for the industry. The advanced multimodal image automatic matching and integration technology of Broncus serves as the cornerstone for operations with flexible lung surgical robots.

手术机器人能够在人体腔内狭窄的空间内完成精确的外科手术，已成为该行业重要的创新智能医疗设备。Broncus先进的多模式图像自动匹配和集成技术是灵活的肺部手术机器人操作的基石。

Given the existing needs for flexible operation in the narrow space of tracheobronchial lumens, to tackle the clinical pain points and to meet market demand, the deployment of natural orifice transluminal (trans-bronchial) surgical robot products in the industry is imperative..

鉴于目前在气管支气管腔狭窄空间灵活操作的需求，解决临床疼痛点和满足市场需求，在行业内部署天然孔腔内（经支气管）手术机器人产品势在必行。。

The Target Company is a company specialized in the production and processing of medical devices and the development of software/hardware, and has the innovative manufacturing and intelligent production capabilities. With core technological advantages of Broncus, such as research and development for (i) flexible catheter product, and (ii) fiber optic navigation, software and algorithm of flexible transbronchial surgical robots, it is believed that the Acquisition can supplement related technologies such as robot control and driving system platform development to the Group, allowing the Group to leverage on the complementary resource integration and further strengthen the innovation of its existing interventional pulmonology diagnosis and treatment products offered..

目标公司是一家专门从事医疗器械生产和加工以及软件/硬件开发的公司，具有创新的制造和智能生产能力。凭借Broncus的核心技术优势，如（i）柔性导管产品的研发，（ii）柔性经支气管外科机器人的光纤导航，软件和算法，相信该采集可以补充相关技术，如机器人控制和驾驶系统平台开发，使该小组能够利用补充资源整合，并进一步加强其现有介入性肺病诊断和治疗产品的创新。。

Furthermore, the Acquisition is expected to strengthen the research and development capabilities and efficiency of the Company (in particular, for the flexible robot projects), enrich the current product offering of the Group through combining with the existing interventional diagnosis and treatment methods of the Company for lung diseases, and further assemble a full life-cycle interventional pulmonology diagnostic and therapeutic platform..

此外，预计收购将加强公司的研发能力和效率（特别是灵活的机器人项目），结合公司现有的介入诊断和治疗方法，丰富集团目前的产品供应。肺部疾病，并进一步组装完整的生命周期介入肺病诊断和治疗平台。。

SOURCE Broncus Holding Corporation

SOURCE Broncus Holding Corporation